APA (7th ed.) Citation

Sancho-Saldaña, A., Gil Sánchez, A., Quirant-Sánchez, B., Nogueras, L., Peralta, S., Solana, M. J., . . . Brieva, L. (2022). Seroprevalence of SARS-CoV-2 in a Cohort of Patients with Multiple Sclerosis under Disease-Modifying Therapies. Journal of Clinical Medicine, 11(9), 2509. https://doi.org/10.3390/jcm11092509

Chicago Style (17th ed.) Citation

Sancho-Saldaña, Agustín, et al. "Seroprevalence of SARS-CoV-2 in a Cohort of Patients with Multiple Sclerosis Under Disease-Modifying Therapies." Journal of Clinical Medicine 11, no. 9 (2022): 2509. https://doi.org/10.3390/jcm11092509.

MLA (9th ed.) Citation

Sancho-Saldaña, Agustín, et al. "Seroprevalence of SARS-CoV-2 in a Cohort of Patients with Multiple Sclerosis Under Disease-Modifying Therapies." Journal of Clinical Medicine, vol. 11, no. 9, 2022, p. 2509, https://doi.org/10.3390/jcm11092509.